KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $238.0 million.

  • Merck's Non Operating Income rose 4691.36% to $238.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.0 million, marking a year-over-year increase of 10400.0%. This contributed to the annual value of $24.0 million for FY2024, which is 10515.02% up from last year.
  • Latest data reveals that Merck reported Non Operating Income of $238.0 million as of Q3 2025, which was up 4691.36% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Merck's Non Operating Income ranged from a high of $455.0 million in Q1 2021 and a low of -$708.0 million during Q1 2022
  • Moreover, its 5-year median value for Non Operating Income was $7.0 million (2025), whereas its average is -$16.7 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first soared by 74084.51% in 2021, then crashed by 52524.27% in 2022.
  • Quarter analysis of 5 years shows Merck's Non Operating Income stood at $334.0 million in 2021, then tumbled by 77.54% to $75.0 million in 2022, then plummeted by 204.0% to -$78.0 million in 2023, then tumbled by 62.82% to -$127.0 million in 2024, then skyrocketed by 287.4% to $238.0 million in 2025.
  • Its Non Operating Income was $238.0 million in Q3 2025, compared to $7.0 million in Q2 2025 and $35.0 million in Q1 2025.